Pharmacokinetic Study in Elderly Patients With Chronic Obstructive Bronchitis (COPD)
NCT02172326 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 29
Last updated 2014-06-24
Summary
Study to evaluate the pharmacokinetics of tiotropium following 14 days of administration (18µg once per day) in elderly COPD patients.
Conditions
- Pulmonary Disease, Chronic Obstructive
Interventions
- DRUG
-
Tiotropium inhalation capsules for oral inhalation
Powder inhalation via HandiHaler®
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-02-28
- Primary Completion
- 1998-09-30
More Related Trials
-
A Study to Characterize Pharmacokinetics of Tiotropium + Olodaterol Fixed-dose Combination in Japanese Patients With COPD.
NCT01703845 ·Status: COMPLETED ·Phase: PHASE1
-
Tiotropium and Salmeterol PK Study in COPD Patients
NCT00673478 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01613326 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT02172469 ·Status: COMPLETED ·Phase: PHASE3
-
Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD Patients
NCT02969317 ·Status: COMPLETED ·Phase: PHASE1
-
Lung Function Changes Following the Addition of Formoterol to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02242240 ·Status: COMPLETED ·Phase: PHASE2
-
Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol on Muscular Efficiency and Resting Energy Expenditure (REE) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)
NCT02172794 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Tiotropium on Inflammation and Exacerbations in COPD
NCT00405236 ·Status: COMPLETED ·Phase: PHASE4
-
Free Combinations of Tiotropium Inhalation Powder Capsule + Salmeterol Metered Dose Inhaler, Tiotropium Inhalation Powder Capsule and Salmeterol Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02242253 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Ba679BR Powder Inhalation in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02172807 ·Status: COMPLETED ·Phase: PHASE3
-
Anti-inflammatory Effects of Tiotropium in Patients with Stable COPD
NCT04061161 ·Status: COMPLETED ·Phase: PHASE4
-
A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler
NCT02172560 ·Status: COMPLETED
-
A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)
NCT00239434 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPD
NCT00535366 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Free Combination of Tiotropium + Formoterol Compared to Formoterol and Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02238119 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00274092 ·Status: COMPLETED ·Phase: PHASE3
-
A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)
NCT00239421 ·Status: COMPLETED ·Phase: PHASE4
-
Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02172287 ·Status: COMPLETED ·Phase: PHASE3
-
QualiTy of Life Evaluation in Patients With ChRonic ObstructIve Pulmonary Disease Who Require Tiotropium as additiOnal treatmeNt.
NCT06170125 ·Status: NOT_YET_RECRUITING
-
Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to Triple Therapy
NCT04184297 ·Status: COMPLETED
-
Effects of Tiotropium on Walking Capacity in Patients With COPD
NCT01307189 ·Status: COMPLETED ·Phase: PHASE4
-
A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.
NCT00274560 ·Status: COMPLETED ·Phase: PHASE3
-
Cardiac Limitations in Chronic Obstructive Pulmonary Disease: Benefits of Bronchodilation
NCT00578968 ·Status: COMPLETED ·Phase: PHASE4
-
Differential Trough Effects of 'Triple Therapy' on Pulmonary Function in Chronic Obstructive Pulmonary Disease (COPD)
NCT00996697 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Initiating Tiotropium Alone Versus Initiating Tiotropium in Combination With Fluticasone Propionate/Salmeterol Xinafoate Combination (FSC) on Chronic Obstructive Pulmonary Disease-related Outcomes in Patients With Pre-existing Exacerbations
NCT01381406 ·Status: COMPLETED